Table 1.
SNPs showing the strongest association with AMD
SNP | Allele |
Risk allele frequency | lod, 1 df | P | Penetrances |
λsib | RR1 | RR2 | Logistic regression, including covariates for the following |
||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Risk (−) | Nonrisk (+) | +/+ | +/− | −/− | rs10490924 | rs11200638 | |||||||
rs10490924 | T | G | 0.284 | 28.12 | 5.3 × 10−30 | 0.092 | 0.245 | 0.652 | 1.275 | 2.656 | 7.054 | NA | 6.27 × 10−8 |
rs3750847 | T | C | 0.247 | 18.95 | 9.4 × 10−21 | 0.114 | 0.264 | 0.61 | 1.191 | 2.313 | 5.347 | 0.067 | 0.003 |
rs3793917 | G | C | 0.243 | 17.75 | 1.6 × 10−19 | 0.116 | 0.265 | 0.603 | 1.182 | 2.275 | 5.174 | 0.051 | 0.002 |
rs3750848 | G | T | 0.246 | 17.45 | 3.1 × 10−19 | 0.117 | 0.263 | 0.594 | 1.178 | 2.253 | 5.080 | 0.103 | 0.008 |
rs11200638 | A | G | 0.248 | 17.36 | 3.8 × 10−19 | 0.118 | 0.262 | 0.577 | 1.167 | 2.207 | 4.872 | 0.241 | NA |
rs932275 | A | G | 0.235 | 14.75 | 1.7 × 10−16 | 0.12 | 0.269 | 0.601 | 1.172 | 2.238 | 5.007 | 0.140 | 0.050 |
rs2672587 | G | C | 0.254 | 14.19 | 6.3 × 10−16 | 0.123 | 0.256 | 0.534 | 1.142 | 2.086 | 4.351 | 0.137 | 0.124 |
rs2253755 | G | A | 0.312 | 8.54 | 3.6 × 10−10 | 0.132 | 0.23 | 0.398 | 1.078 | 1.736 | 3.014 | 0.027 | 0.017 |
rs2248799 | T | C | 0.494 | 7.97 | 1.4 × 10−9 | 0.112 | 0.188 | 0.316 | 1.066 | 1.680 | 2.820 | 0.307 | 0.421 |
rs10510110 | C | T | 0.51 | 5.75 | 2.7 × 10−7 | 0.116 | 0.187 | 0.302 | 1.055 | 1.612 | 2.599 | 0.347 | 0.531 |
For each SNP, the risk allele (−) is defined as the allele with increased frequency in affected individuals. Evidence for association, as evaluated by the LAMP program (26), is summarized through the risk allele frequency in the population (estimated using a parametric model that, in effect, weights cases and controls according to the estimated disease prevalence); lod (logarithm of odds) score (log10 likelihood ratio statistic comparing model with and without association); P value; and a series of estimated penetrances for nonrisk homozygotes (+/+), heterozygotes (+/−), and risk allele homozygotes (−/−); genotype relative risks RR1 and RR2 (which are computed by comparing estimated penetrances in heterozygotes and risk-allele homozygotes, respectively, and those for nonrisk homozygotes); and sibling recurrence risks λ sib. The λ sib measure characterizes the overall contribution of a locus to disease susceptibility. It quantifies the increase in risk to siblings of affected individuals attributable to a specific locus (48). For example, λsib of 1.27 signifies that the SNP could account for 27% in risk of AMD for relatives of affected individuals. Association analysis using a simple χ 2 statistic produced similar results. The last two columns summarize P value results of logistic regression analysis, including either rs10490924 or rs11200638 as covariates. As suggested in ref. 40, missing genotypes were imputed prior to the sequential analyses reported in the last two columns.